• Home
  • Immunotherapy for early triple negative breast cancer: research agenda for the next decade.

Immunotherapy for early triple negative breast cancer: research agenda for the next decade.

Author List
Tarantino P, Corti C, Schmid P, Cortes J, Mittendorf EA, Rugo H, Tolaney SM, Bianchini G, Andrè F, Curigliano G
Publication
NPJ breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/269269697
Publication Year
2022
PubMed ID
35181659
Publication Title
Tarantino P, Corti C, Schmid P, Cortes J, Mittendorf EA, Rugo H, Tolaney SM, Bianchini G, Andrè F, Curigliano G. Immunotherapy for early triple negative breast cancer: research agenda for the next decade. NPJ Breast Cancer. 2022 Feb 18; 8(1):23.